Programs

Novartis Holds Media Workshop & Writing Contest on New Breakthrough in Hypertension Management

Hypertention is the world's number one killer. It is estimated more than 1 billion people globally or one (1) of four (4) adult has hypertension problem. This number is predicted to increase to be 1,6 billion by 2025.

Often times, patients are not aware of hypertension, that is why it is known as the 'silent killer'. Not to mention the low awareness and knowledge about the disease which has led to incorrect or insufficient treatment.

After 40 years of researches to investigate an optimal therapy approach, a new breakthrough on hypertension therapy which works within the Renin system (Direct Renin Inhibitor) is established as the most current therapy approach to control hypertension to optimal level.

Direct Renin Inhibitors (DRI) is a therapy approach which works within the Renin system in the body which is central to blood pressure regulation. By directly inhibiting the system's point of activation - Renin - a direct renin inhibitor decreases the activity of the Renin System, as measured by plasma renin activity (PRA).

To be able to further explore the potential of Renin inhibitor (Direct Renin Inhbitor/DRI) in hypertension, Novartis Indonesia has taken an initiative to hold a Media Workshop and Media Writing Competition on the breakthrough of hypertension management. This workshop will be featuring Prof.DR.dr. Budi Setianto, SpJP, hypertension expert from National Heart Centre, Harapan Kita, Heart and Blood Vessel Hospital.

Media Writing Competition
The key objective of Novartis Media Writing Competition is to increase the spread of information, knowledge, understanding and management (4Ps) on hypertension to Indonesian public. More specific, this initiative is expected to increase public awareness on the breakthrough in future hypertension management, e.g Direct Renin Inhibitor.

The committee has established several criterias for this competition, such as : candidate is a print / online journalist in Indonesia with interest in hypertension; the participant should also write the article by using the mentioned theme.

The judges are coming from 3 elements ,e.g Dr dr Faisal Baraas SpJp (hypertension expert), Nugroho Dewanto (Tempo journalist and member of Aliansi Jurnalis Indonesia), and dr Wibawa Roan (Medical Affairs Manager Novartis Indonesia). By having three parties as the judges, it is hoped that independency can be maintained during the judging process.

Further information on this competition can be seen at our site: www.id.novartis.com or by contacting the committee of Media Writing Competition at Novartis Indonesia, Wisma 46, Kota BNI, Lt.35 Jakarta, phone/fax : 021-2513251 / 021-5747455, email:wanda.harahap@novartis.com or peduli.hipertensi@novartis.com

For references, please click here

For registration form, please click here